Xconomy San Diego

Visiogen, Inc. Garners $40,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0cb58a60-3209-40b8-8884-18f10b9a59c6&Preview=1
Date
4/27/2009
Company Name
Visiogen, Inc.
Mailing Address
2 Goodyear Irvine, CA 92618
Company Description
Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen’s first commercial application, Synchrony®, a dual-optic intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and recently received a CE Mark in Europe.
Website
http://www.visiogen.com
Transaction Type
Venture Equity
Transaction Amount
$40,000,000
Transaction Round
Undisclosed
Proceeds Purposes
“The funds we have raised will give us the flexibility and resources necessary to maximize the commercial impact of the Synchrony IOL,” said Reza Zadno, CEO and Founder of Visiogen, Inc.
M&A Terms
Venture Investor
Novartis
Venture Investor
Three Arch Partners
Venture Investor
Technology Partners
Venture Investor
New Leaf Venture Partners
Venture Investor
Prospect Venture Partners
Venture Investor
CMEA Ventures
Venture Investor
Foundation Medical Partners